Lobbying Filing Details

Total Spending

$10,000

Activities

1

Lobbyists

1

Gov't Entities

2

Filing Information
Filing UUID:
4d0eed3e-f42d-4265-95df-e6d5899ba132
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 17, 2026 at 1:45 AM
Income:
$10,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Greg Chesmore
Registrant
GRIDIRON PUBLIC AFFAIRS, LLC
Madison, Wisconsin
Client
BEAM THERAPEUTICS

Biotech/biopharmaceutical companies

Massachusetts, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Issues related to patient access to innovative therapies, H.R. 7871 - MVP Act, H.R. 5187 - Sickle Cell Disease, H.R. 7837 - Most Favored Nation Drug Pricing

Lobbyists (1)
  • GREG CHESMORE
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.